Mod­er­na lays off man­u­fac­tur­ing work­ers in Mass­a­chu­setts to 're­size' Covid-19 foot­print

Last year
People
Manufacturing

Achieve Life Sci­ences nabs $124M; Pierre Fab­re buys pan-RAF pro­gram from Kin­nate

Last year
News Briefing

Ex­clu­sive: Backed by MIT’s An­drew Lo, Quan­tile Health rais­es $6M to bol­ster gene ther­a­py ac­cess

Last year
Financing
Cell/Gene Tx

Fog­Phar­ma bags $145M, adds Alex­is Borisy to the board 

Last year
Financing
Startups

Big em­ploy­ers lay out what they want out of obe­si­ty care

Last year
Health Tech

Cardiff teas­es on­va­nsert­ib ef­fi­ca­cy in col­orec­tal can­cer ahead of first-line read­out

Last year
R&D

Grit­stone bio lays off 40% of staff fol­low­ing Covid vac­cine tri­al de­lay

Last year
People
R&D

Pfiz­er names a VC leader in year of re­set; For­mer Ax­cel­la CEO moves on af­ter com­pa­ny shut­down

Last year
People
Peer Review

House com­mit­tee de­bates IRA changes that would im­pact or­phan drugs and oth­er ar­eas

Last year
Pharma
FDA+

Join­ing con­gres­sion­al skep­ti­cism of Chi­na's role in biotech, Biden ex­ec­u­tive or­der tar­gets da­ta pri­va­cy is­sues

Last year
China
Law

Phar­ma lags be­hind health­care in AI adop­tion, but many ex­pect wider use in next few years, study finds

Last year
Pharma
Marketing

Bel­har­ra CEO talks the ins and outs of build­ing a biotech in a new pod­cast

Last year
Pharma
Marketing

San­doz pays out $265M to set­tle part of an­titrust law­suit

Last year
Pharma
Law

Biden ad­min­is­tra­tion in­vests $48M in AI/ML plat­form to iden­ti­fy rare dis­ease drugs

Last year
AI
Pharma

Telix boosts in-house ra­dio­phar­ma man­u­fac­tur­ing; Dy­navax im­proves vac­cine pro­duc­tion costs

Last year
Manufacturing

Eu­roAPI’s blue­print for ‘lean­er’ op­er­a­tions in­cludes drop­ping prod­ucts, po­ten­tial lay­offs and sites put on ice

Last year
Manufacturing

Avid­i­ty to raise $400M; Sato pays Ar­cutis $25M up­front to li­cense top­i­cal rof­lu­mi­last in Japan

Last year
News Briefing

Chan Zucker­berg Ini­tia­tive funds four grants to cre­ate re­gion­al net­works of re­searchers

Last year
R&D

Iron­wood’s stock drops 40% as short bow­el syn­drome drug shows mixed ef­fi­ca­cy in PhI­II

Last year
R&D

'Sweet spot' of CNS cell ther­a­py: Ke­nai emerges with $82M for Parkin­son's study

Last year
Financing
Startups

Blos­somHill rais­es $100M in bid to re­peat founder­s' can­cer suc­cess at Turn­ing Point

Last year
Financing
Startups

Sarep­ta touts Duchenne gene ther­a­py up­take, but warns of de­mand flat­ten­ing be­fore po­ten­tial ex­pand­ed la­bel from FDA

Last year
Pharma
Cell/Gene Tx

Io­vance’s Am­tagvi sees ‘healthy de­mand’ af­ter US ap­proval

Last year
Pharma
Cell/Gene Tx

No­vo Hold­ings in­vests in macro­cy­cle start­up Or­bis as once-over­looked mol­e­cules get new in­ter­est

Last year
Financing
Startups
First page Previous page 192193194195196197198 Next page Last page
A service from the Financial Times